Kclavis

Kclavis is a Seoul-based company founded in 2013 that focuses on generating stable returns for its customers through investments and asset management services, particularly catering to technology-driven companies.

Noh Young seok

CEO

20 past transactions

R&R Lab

Venture Round in 2024
R&R Lab is a semiconductor manufacturing startup that develops heat treatment equipment.

Nuon Media

Series A in 2022
Nuon Media is an Internet e-book store that sells famous domestic romance martial arts fantasy fantasy novels.

Inkle

Seed Round in 2022
Inkle is a facility data platform that offers industrial software technology services for equipment makers and producers.

HandHug

Series A in 2022
HandHug is a content commercialization company that operates an e-commerce platform designed to facilitate the creation and sale of products and brands in collaboration with creators. The company provides essential infrastructure that enables creators to develop new products, build their brands, and effectively market their offerings. By focusing on collaborations with creators, HandHug aims to streamline the process of product development and commercialization, thereby enhancing the potential for success in the competitive e-commerce landscape.

Selecxine

Series B in 2022
Selecxine is a biopharmaceutical development company focused on creating innovative immunotherapeutics for cancer treatment. The company specializes in the development of anti-cancer drugs that enhance the body's immune response through a unique antibody development process. By utilizing a cutting-edge platform for functional antibody screening, Selecxine aims to regulate the activity of cytokines, which are crucial for activating immune cells. This approach is designed to provide safer and more effective therapeutic options for cancer patients, ultimately improving their survival rates and quality of life.

Korea Credit Data

Series D in 2021
Korea Credit Data Co., Ltd. is a Seoul-based company that specializes in developing business management software, particularly for small and medium enterprises. Founded in 2016, its flagship product, CashNote, enables users to manage card payment schedules, conduct customer analysis, and perform tax invoice inquiries. In addition to CashNote, Korea Credit Data offers a range of services that include customer analysis, point-of-sale (POS) systems, and payment solutions through its various subsidiaries. The company serves over two million businesses in Korea, aiming to address challenges faced by business owners throughout their operational lifecycle. By forming strategic partnerships with leading industry players, Korea Credit Data has established a strong market presence and expanded its offerings to include payment networks and credit bureau services, enhancing its ability to support its clients effectively.

StradVision

Series C in 2021
StradVision, established in 2014, specializes in developing perception algorithms for advanced driver assistance systems (ADAS) and autonomous vehicles. Headquartered in San Jose, USA, with R&D centers globally including South Korea, the company offers SVNet External for external object detection and SVNet Internal for occupant monitoring. Its Auto Labeling Tool automates object annotation for training data generation. StradVision's machine learning algorithms have achieved top performance in global tech evaluations, running smoothly on embedded devices. With over 60 issued patents and extensive industry backing, the company aims to democratize self-driving technology through safe, accurate real-world perception capabilities.

BeyondBio

Venture Round in 2021
BeyondBio is a biotechnology company focused on researching and developing synthetic pharmaceutical drugs. Its primary objective is to create therapeutic agents for diseases currently lacking effective treatments, such as pancreatic cancer, Alzheimer's disease, and glioblastoma. By advancing innovative drug candidates and therapies, BeyondBio aims to enable medical practitioners to better protect patients from life-threatening conditions.

Panolos Bioscience

Series A in 2021
Panolos Bioscience is a biotechnology company focused on developing innovative biological drugs for cancer therapy. The company utilizes a multi-specific drug creation platform, which features anti-angiogenesis-based artifact re-targeting tri-specifics, known as ART. This technology aims to minimize the side effects commonly associated with single-target protein therapeutics and supports the expansion of diverse drug pipelines through its multi-targeting approach. By offering novel drugs and treatment options, Panolos Bioscience strives to improve patient outcomes in cancer care.

Lemonex

Series C in 2021
Lemonex Inc. is a biotechnology company based in Seoul, South Korea, that focuses on developing and commercializing innovative solutions for cancer treatment and other intractable diseases. Founded in 2013, the company specializes in cancer immunotherapeutics, antibody therapeutics, and gene therapeutics. Lemonex is known for its drug delivery technology, including DegradaBALL, which facilitates the internalization of drug candidates into cultured cells and lesions. Additionally, it has developed PANGO, a drug screening technology that enables rapid evaluation of antiviral drugs from a library of candidates. With a commitment to advancing biotherapeutics, Lemonex aims to enhance the efficacy and precision of drug delivery in clinical settings.

Korea Credit Data

Series C in 2021
Korea Credit Data Co., Ltd. is a Seoul-based company that specializes in developing business management software, particularly for small and medium enterprises. Founded in 2016, its flagship product, CashNote, enables users to manage card payment schedules, conduct customer analysis, and perform tax invoice inquiries. In addition to CashNote, Korea Credit Data offers a range of services that include customer analysis, point-of-sale (POS) systems, and payment solutions through its various subsidiaries. The company serves over two million businesses in Korea, aiming to address challenges faced by business owners throughout their operational lifecycle. By forming strategic partnerships with leading industry players, Korea Credit Data has established a strong market presence and expanded its offerings to include payment networks and credit bureau services, enhancing its ability to support its clients effectively.

TESSA

Seed Round in 2021
TESSA is an alternative investment platform that facilitates the purchase, sale, and trade of fractionalized ownership interests in investment-grade blue-chip artwork. By tokenizing these artworks, TESSA allows micro-collectors to co-own pieces from renowned artists such as Warhol, Picasso, Kusama, and Basquiat, while providing the accessibility and liquidity akin to public markets. The platform manages all aspects of the artwork, including maintenance and administrative services, while promoting and displaying the pieces to enhance their value and visibility. TESSA ensures a transparent and secure management of ownership certificates, transaction history, and transfer status through a blockchain network and trusted third-party service providers. This innovative approach enables users to appreciate art and engage in art investment in a more accessible manner.

Bertis

Venture Round in 2020
Bertis Inc. is a proteomics-based molecular diagnostics company founded in 2014 and headquartered in Seongnam, South Korea. The company specializes in the development and commercialization of cancer-related biomarkers aimed at early disease detection. Its flagship product, Mastocheck, provides a screening method for diagnosing stage 1 breast cancer. Additionally, Bertis is engaged in research to create biomarkers for the early diagnosis of various carcinomas and to develop new therapeutic markers and co-markers. The company employs advanced bio-big data analysis technologies to discover and develop markers that integrate proteomics, genomics, and bioinformatics, enhancing the diagnostic capabilities for cancer and cardiac diseases.

Parameta

Series B in 2020
Parameta is a technology company specializing in blockchain solutions, focused on delivering comprehensive technical support for leading global blockchain initiatives. Established in 2016 and headquartered in Seoul, South Korea, Parameta enhances the functionality and security of existing blockchain platforms. The company leverages its proprietary technologies, including SCORE Smart Contract, LFT Algorithm, and modular architecture, to optimize scalability and maximize the utility of blockchain applications. Through these innovations, Parameta aims to facilitate the implementation and execution of efficient blockchain systems across various industries.

Amyloid Solution

Series B in 2020
Amyloid Solution Inc., headquartered in Seongnam, South Korea, is a biopharmaceutical company dedicated to developing innovative therapies for Alzheimer's disease. The company focuses on understanding and targeting the underlying pathophysiological events driving disease progression to discover novel, disease-modifying treatments. Their mission is to provide effective solutions for patients with Alzheimer's disease at various stages and pathological alterations.

Kasa

Series A in 2019
Kasa Korea Co., Ltd. is a company based in Seoul, South Korea, that specializes in developing a digital securities blockchain platform tailored for the real estate market. Established in 2018, Kasa's platform enables users to buy and trade securitized commercial real estate assets as asset-backed securities. By leveraging blockchain technology, the company aims to provide retail investors with a transparent and streamlined process for investing in real estate, facilitating the buying and selling of securitized assets in a more efficient manner.

MDimune

Series B in 2019
MDimune Inc. is a South Korean therapeutics company focused on developing innovative drug delivery systems. Founded in 2015 and based in Seoul, the company specializes in the creation of cancer therapeutics using immune cell-derived and stem cell-derived vesicles. Its research and development efforts encompass a range of therapeutic areas, including personalized cancer treatments, osteoarthritis, chronic obstructive pulmonary disease, and neurodegenerative disorders. MDimune's proprietary platform enables targeted delivery of drugs, allowing for the development of novel therapeutics that enhance treatment efficacy. The company provides its vesicle-based delivery solutions to biotech and pharmaceutical enterprises, thereby facilitating advanced therapeutic options for patients.

Datable

Series A in 2019
Datable Inc. is a company that specializes in developing digital marketing tools and services focused on data analysis. Founded in 2016 and headquartered in Seoul, South Korea, Datable creates mobile applications specifically tailored for influencer marketing. The company's solutions aim to enhance the effectiveness of marketing campaigns by leveraging data-driven insights.

Doc Talk

Seed Round in 2018
Doc Talk is a messenger platform that connects patients and doctors.

Bob Games

Seed Round in 2017
A Social casino game developer.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.